Scarica l'app Stockscreener
8.61
1.29%
0.11
Dopo l'orario di chiusura:
8.55
-0.06
-0.70%
Precedente Chiudi:
$8.50
Aprire:
$8.61
Volume 24 ore:
834.26K
Relative Volume:
0.74
Capitalizzazione di mercato:
$753.47M
Reddito:
-
Utile/perdita netta:
$-95.90M
Rapporto P/E:
-6.5227
EPS:
-1.32
Flusso di cassa netto:
$-79.09M
1 W Prestazione:
+1.29%
1M Prestazione:
+17.95%
6M Prestazione:
+284.37%
1 anno Prestazione:
+12.55%
Intervallo 1D:
$8.55
$9.0316
Intervallo di 1 settimana:
$7.91
$9.0316
Portata 52W:
$1.865
$9.0316
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Nome
Terns Pharmaceuticals Inc
Settore
Industria
Telefono
650-525-5535 EXT.101
Indirizzo
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Confronta TERN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
8.61 | 707.09M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-04 | Ripresa | H.C. Wainwright | Neutral |
| 2025-02-28 | Iniziato | William Blair | Mkt Perform |
| 2024-10-31 | Iniziato | Oppenheimer | Outperform |
| 2023-06-22 | Iniziato | Mizuho | Buy |
| 2023-06-07 | Iniziato | Jefferies | Buy |
| 2023-05-31 | Iniziato | ROTH MKM | Buy |
| 2023-05-08 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-14 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-02-07 | Iniziato | UBS | Buy |
| 2022-09-12 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-14 | Ripresa | Goldman | Buy |
| 2021-03-02 | Iniziato | Cowen | Outperform |
| 2021-03-02 | Iniziato | Goldman | Buy |
| 2021-03-02 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
Vontobel Holding Ltd. Trims Holdings in Terns Pharmaceuticals, Inc. $TERN - Defense World
Terns Pharma (TERN): Truist Securities Initiates Coverage with B - GuruFocus
Truist Securities initiates Terns Pharmaceuticals stock with Buy rating By Investing.com - Investing.com UK
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceInflation Watch & High Return Trade Guides - newser.com
How Terns Pharmaceuticals Inc. stock valuations compare to rivalsEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Tick level data insight on Terns Pharmaceuticals Inc. volatilityTrade Analysis Summary & Low Risk Entry Point Tips - newser.com
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
What analysts say about Terns Pharmaceuticals Inc stockMean Reversion Trades & Secret Picks Wall Street Isn’t Talking About - earlytimes.in
Detecting price anomalies in Terns Pharmaceuticals Inc. with AIPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Using data models to predict Terns Pharmaceuticals Inc. stock movementQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Is it too late to sell Terns Pharmaceuticals Inc.2025 Year in Review & High Accuracy Trade Alerts - newser.com
Terns Pharmaceuticals Inc Stock Analysis and ForecastCup and Handle Formations & Interactive Charts for Smarter Trading - earlytimes.in
How to recover losses in Terns Pharmaceuticals Inc. stockWeekly Stock Recap & Growth Focused Entry Reports - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Predicting Terns Pharmaceuticals Inc. trend using moving averages2025 Key Lessons & Fast Gain Stock Tips - newser.com
Volume spikes in Terns Pharmaceuticals Inc. stock – what they meanJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ... - Enidnews.com
118,000-share grant: Terns Pharmaceuticals awards inducement options at $7.81 with 10-year term - Stock Titan
MarketsMedicine Hat News - FinancialContent
Does Terns Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely - Yahoo Finance
Terns Pharmaceuticals: Valued As If It Can't Win - Seeking Alpha
Is Terns Pharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Yield Stock Picks - earlytimes.in
Will Terns Pharmaceuticals Inc. stock see insider buyingDollar Strength & Daily Entry Point Alerts - The British Mountaineering Council
Exchange Traded Concepts LLC Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Full technical analysis of Terns Pharmaceuticals Inc. stockTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Goldman Sachs Group Inc. Has $1.15 Million Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Technical analysis overview for Terns Pharmaceuticals Inc. stockWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Can Terns Pharmaceuticals Inc. rally from current levels2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
2 Under-the-Radar Stocks That Could Soar - Mitrade
Fed Meeting: Is Terns Pharmaceuticals Inc a top pick in the sectorJuly 2025 Opening Moves & Fast Gain Swing Alerts - خودرو بانک
Aug Wrap: Is Terns Pharmaceuticals Inc stock a good dividend stockWeekly Stock Analysis & Fast Exit Strategy with Risk Control - خودرو بانک
Analyzing Terns Pharmaceuticals Inc. with multi timeframe charts2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
How high can Terns Pharmaceuticals Inc. stock goQuarterly Portfolio Report & Consistent Return Strategy Ideas - newser.com
Published on: 2025-09-19 23:29:17 - خودرو بانک
Profit Review: Will Terns Pharmaceuticals Inc benefit from current market trendsJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک
Trend analysis for Terns Pharmaceuticals Inc. this weekBreakout Watch & Real-Time Volume Analysis Alerts - newser.com
Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Terns Pharmaceuticals Inc Azioni (TERN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kuriakose Emil | Chief Medical Officer |
Jul 01 '25 |
Sale |
4.27 |
853 |
3,640 |
52,464 |
| Gengos Andrew | Chief Financial Officer |
Jun 27 '25 |
Buy |
3.93 |
10,000 |
39,283 |
25,000 |
| Burroughs Amy L. | Chief Executive Officer |
Jun 25 '25 |
Buy |
3.87 |
23,314 |
90,230 |
47,083 |
| Gengos Andrew | Chief Financial Officer |
Jun 13 '25 |
Buy |
3.73 |
10,000 |
37,350 |
10,000 |
| Gengos Andrew | Chief Financial Officer |
Jun 16 '25 |
Buy |
3.95 |
5,000 |
19,732 |
15,000 |
| Kuriakose Emil | Chief Medical Officer |
Apr 01 '25 |
Sale |
2.49 |
952 |
2,366 |
53,317 |
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):